Japanese scientists were involved in pioneering work on therapeutic antisera and have made huge contributions to the characterization of the antibody molecules that are responsible for this and many other biological activities, as well as working back to understand the B cells that produce these Igs. This review emphasizes the role of Japanese immunologists in this field, starting with their work in developing antisera and studying the structure of Igs. It describes the molecular mechanisms that generate the enormous antibody repertoire and regulate B-cell development and signaling. It also details the importance of the germinal center in generating B-cell memory and the terminal differentiation of B cells as antibody-secreting plasma cells.
Introduction
Innate immunity and acquired immunity are the two arms of the host defense system, B cells and antibodies being important elements of acquired humoral immunity in the fight against various pathogens. A number of Japanese scientists have made significant contributions to clarification of Ig structure, antibody diversity mechanisms, B-cell differentiation processes and signal cascades from the BCR. Here, I present a historical sketch of the study of B cells and antibodies made by Japanese scientists by chronologically describing a number of epoch-making studies by several researchers in Japan and elsewhere.
The discovery of anti-toxin antibodies: Shibasaburo Kitasato
Antibodies made by effector B cells are one of the main selfdefense biomolecules against various types of pathogens. In this sense, the study of B cells and their antibodies was begun by Baron Shibasaburo Kitasato (1853 Kitasato ( -1931 . Kitasato was historically well known as a pioneer in the field of microbiology and was the first to succeed in the pure culture of tetanus bacillus in 1889 and to disclose its pathogenic properties (1) . Furthermore, it is notable that Kitasato and Emil Adolf von Behring discovered a tetanus-neutralizing antitoxin in blood serum (i.e. an antiserum) and clearly showed its ability to protect against tetanus infection by injecting such sera from other animals infected with the disease (2) . This study was widely recognized to the extent that the use of antisera against various pathogens became a routine method of treating diseases; antibodies are now known to be the crucial components within antisera.
The discovery of IgE, a new class of Ig: Kimishige Ishizaka and Teruko Ishizaka
Japanese immunologists of whom I should make special mention in the field of B cells and antibodies are Kimishige Ishizaka and his wife, Teruko Ishizaka. Kimishige and Teruko Ishizaka are also known as excellent mentors and supervisors, having trained many Japanese researchers in the field of immunology. They published an epoch-making paper in 1966 (3) at the Children's Asthma Research Institute and Hospital, Denver, where they first identified the reaginic component in the sera of ragweed-sensitive patients. Using an immunodiffusion method and immunoelectrophoresis of 131 I-labeled specimens, they determined that this unique Ig was a novel isotype distinct from the already identified IgG, IgM, IgD and IgA and also confirmed that this new class of Ig is actually reaginic using the Prausnitsz-Kustner reaction. The c1 precipitin or c1-globulin was tentatively named cE-globulin in their paper and is now known as IgE (Fig. 1 ).
The structure of IgM: Kaoru Onoue, Tadamitsu Kishimoto and Yuichi Yamamura
The next players to enter the field of B cells and antibodies were Kaoru Onoue (Kyushu University) and Tadamitsu Kishimoto (currently at Osaka University) who, with Yuichi Yamamura (Osaka University), concentrated on elucidating the structure of IgM. After the discovery of heavy molecular weight c-globulin (IgM) in the sera of patients with macrogloburinemia by Waldenstrom (1944) (4) and also in normal human sera by Deutsch (1956) (5) , the basic structure of IgM was examined by Miller and Metzger (1965) (6) and by Lamm and Small (1966) (7) , who reported that IgM is composed of five subunits, each having two heavy (H) and two light (L) chains.
On the basis of these findings, Onoue and Kishimoto clarified the subunit structure of human IgM (obtained from the serum of a patient with macroglobulinemia) by using a combination of physicochemical techniques, gel filtration, ultracentrifugation and immunoelectrophoresis after the digestion of IgM with enzymes (pepsin or papain). In a series of their studies in the late 1960s, they showed that, after papain digestion, human IgM has structurally similar Fab and Fc fragments to those derived from IgG (8, 9) . They summarized the schematic steps in the generation of various fragments from the enzymatic digestion of human IgM [see ref. (10) for schema of this digestion]. This schematic view still provides very valuable, basic information for researchers in this field, for example when analyzing the antigen-binding capacity of the IgM fragments generated by enzyme cleavage.
Ig gene rearrangement: Susumu Tonegawa
How are antigen receptors (and antibodies) with an almost infinite range of specificities encoded by a finite number of genes? This question was answered in 1976 by Susumu Tonegawa ( Fig. 2 ; currently at the Massachusetts Institute for Technology and RIKEN-MIT Center for Neural Circuit Genetics). Tonegawa demonstrated that antibody diversity is the result of gene rearrangement and that the DNA responsible for antibody production is routinely reorganized to create new gene sequences (Fig. 3) .
Before clarifying the gene rearrangement, Tonegawa had argued that the number of germ line genes is too small to account for the diversity of Ig L chains (11, 12) . In 1976, at the Basel Institute for Immunology, Tonegawa presented clear evidence for the somatic rearrangement of Ig genes coding for variable (V) and constant (C) regions; comparing DNA from early embryos of the Balb/c mouse strain with DNA from MOPC 321 plasmacytoma cells (which produce Igj L chains), Tonegawa and Nobumichi Hozumi showed that the pattern of the plasmacytoma DNA is different from that of embryo DNA, suggesting the joining of Vj and Cj genes to form a new functional Ig gene (13) . This striking report paved the way for a series of studies on the mechanism of gene rearrangement (14, 15) . Thereafter, Tonegawa and Hitoshi Sakano (currently at the University of Tokyo) clarified that the somatic recombination is accompanied by excision of an entire DNA segment between the V gene and the J DNA segment (16) .
Activation-induced cytidine deaminase in B-cell class switch recombination and somatic hypermutation: Tasuku Honjo
Here we would like to touch on another somatic recombination event-class switch recombination-of which mechanism was clarified by Tasuku Honjo ( Fig. 4 ; currently at the Kyoto University). Honjo is one of the most famous scientists in Japan and has made substantial contributions to the study of B-cell terminal differentiation that is necessary for efficient antibody responses. Though he has contributed much to the study of B cells and antibodies over many years, I will look here at one epoch-making moleculeactivation-induced cytidine deaminase (AID).
It is well accepted that Ig class switch is a process by which the constant region of the IgH chain is converted from the Cl to the Cc, Ca or Ce chain. In the late 1970s and early 1980s, Honjo first proposed the molecular processes for class switch recombination and its regulation (17) (18) (19) (20) . The mechanism of class switch recombination was confirmed by the discovery of circular DNA, which is excised during this process (21, 22) . Thereafter, Honjo and his group concentrated on elucidating the precise mechanisms underlying class switch recombination and by subtraction of complementary DNAs (cDNAs) derived from switch-induced and non-switch-induced murine B lymphoma CH12F3-2 cells. In 1999, they identified a novel gene referred to as AID, a new member of the RNA-editing deaminase family (23) .
AID mRNA expression is induced in activated B cells, and of note is that AID mRNA is specifically expressed in germinal center (GC) B cells. Furthermore, they showed that the over-expression of AID in B lymphoma cells augments Ig class switch from IgM to IgA, and conversely, AID deficiency causes a complete defect in Ig class switching along with a hyper-IgM phenotype and enlarged GCs (24) . The mutation in the human counterpart of AID was simultaneously reported in patients with the autosomal-recessive form of hyper-IgM syndrome (HIGM2), in which the absence of Ig class switch recombination, the lack of somatic hypermutations and lymph node hyperplasia caused by the presence of giant GCs were observed (25) . The phenotypic abnormalities observed in HIGM2 patients is similar to that observed in AID-deficient mice, and these findings in mice and humans clearly indicate the absolute requirement for AID in both class switch recombination and hypermutation, both being indispensable for generating antibody diversity.
Determining the molecular mechanism by which AID regulates class switch recombination and hypermutation is still puzzling. AID is thought to deaminate cytosine to generate uracil in either mRNA or DNA, and two major hypotheses have thus been proposed: DNA deamination and RNA editing. That is, which one is the target of AID-RNA or DNA? For some years, Honjo's group has focused on this problem (26) and argues that RNA editing is more likely than DNA deamination. However, as Honjo himself states (27) , definitive proof of either of the two hypotheses is yet to come.
The surrogate L chain, pre-BCR and B-cell differentiation: Nobuo Sakaguchi, Akira Kudo, Hajime Karasuyama and Takeshi Tsubata The forementioned studies dealt with mature B cells. How and where these mature B cells are generated are also critical issues. The early developmental stages of B2 cells ('conventional' B cells) are now known to consist of the following sequential steps ( The studies required to clarify the precise mechanisms and related molecules involved in these developmental stages of B cells were critically important, and several Japanese researchers contributed in this area. In 1986, Nobuo Sakaguchi (currently at the Kumamoto University) in the Basel Institute for Immunology first defined a new Ig L chain-related locus, k5, from messenger RNA of the murine pre-B lymphoma cell line 70Z/3 and showed that it was selectively transcribed in pre-B lymphocytes (29) . Later on, Akira Kudo (currently at the Tokyo Institute of Technology), also in the Basel Institute for Immunology, clarified the organization of the k5 gene, which is composed of three exons (30) and is situated on the murine chromosome 16 (31) . Of note is that Kudo further defined a second gene, VpreB, upstream of k5 gene and clarified that this VpreB gene has two exons and is also selectively expressed in pre-B-cell lines (32) .
After a series of experiments, Hajime Karasuyama (currently at Tokyo Medical and Dental University) published a paper showing that complexes consisting of one VpreB, one k5 and one Ig l H chain can be immunoprecipitated by l chainspecific antibodies, indicating that these three proteins can form a heterocomplex resembling a H chain plus a L chain (33) .
At the same time, Takeshi Tsubata (currently at the Tokyo Medical and Dental University), at the Max-Planck Institute 
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for Immunobiology in Freiburg, reported that k5 and VpreB are required for l chain expression on the cell surface and that k5 and VpreB are essential components of the pre-BCR in pre-B cells (34) . Furthermore, the functional importance of the pre-BCR on pre-B cells was also confirmed by Tsubata, who showed that the cross-linking of the pre-BCR on pre-B cells induces activation of V gene rearrangements at the Igj locus (35) . It is now widely accepted that the proteins encoded by the VpreB and k5 genes associate with each other to form a structure that resembles an Ig L chain-and is thus called the 'surrogate L chain'-and that this complex (l chain plus surrogate L chain) can be expressed on the surface of pre-B cells (in large pre-B cells) and plays an important role in B-cell development.
It should be mentioned that cell surface pre-BCR expression also requires the formation of a complex with two other molecules. Sakaguchi contributed here by discovering mb-1, a B-cell-specific cDNA clone, using a murine subtraction library in which pre-B cells were compared with T cells (36) . Later, there was a report showing signal transmission through the MB-1 molecule (the mb-1 gene product) at the pre-B-cell stage (37) . MB-1 is now known as Iga (also known as CD79a; note that this is not the same as IgA), and it forms a complex with a molecule encoded by the B-cellspecific gene B29 (known as Igb or CD79b) (38) . The pre-BCR transmits its cell surface signals to intracellular signal cascades via Iga-Igb. Thus, Iga and Igb are also critical elements for the development of B cells and for signal transduction in mature B cells.
In line with these studies, it is known that, after the stimulation of the pre-BCR in pre-B cells, tyrosine residues in the immunoreceptor tyrosine-based activation motif (ITAM) motif of Iga-Igb are phosphorylated by a tyrosine kinase, Lyn. This is followed by the activation of another tyrosine kinase, spleen tyrosine kinase (Syk), after its association with the phosphorylated ITAM motif of Iga-Igb, resulting in further phosphorylation of adapter molecules such as B-cell linker (BLNK) and CD19 (see later section), thereby inducing the activation of phospholipase Cc (PLCc) and phosphatidylinositol 3-kinase (PI3-kinase), as shown in mature B cells by Kurosaki et al. (39) .
The importance of the m chain in B-cell development: Daisuke Kitamura
As discussed above, the expression of l chain is particularly important for the development of B cells, and Daisuke Kitamura (currently at the Tokyo University of Science) is celebrated for establishing a gene-targeted mouse-a l chaindeficient strain. He was the first Japanese researcher to succeed in generating a gene knockout mouse in the field of immunology. In the 1990s, in Klaus Rajewsky's laboratory at the University of Cologne, Kitamura attempted to clarify the regulatory mechanism of B-cell development and differentiation. As described above, pre-B cells express the pre-BCR (l chain with surrogate L chain) on their cell surface, and the pre-BCR regulates the rearrangement of Ig L chain genes (Fig. 5) .
Kitamura assessed the importance of membrane l chain expression in B-cell development by generating the l chaindeficient mouse (lMT), with homozygous mutation of the membrane exon (40) . Neither mature B cells nor cells expressing IgM plus IgD was detected in these mice, and Bcell development and differentiation were arrested at the pre-B stage. Using these mice, Kitamura also showed that targeted disruption of membrane l chain resulted in the loss of H chain allelic exclusion (41) .
It should be noted that the critical role of k5 in B-cell development was also confirmed by Kitamura using k5 genetargeted mouse; B-cell development in the bone marrow was blocked at the pre-B-cell stage, as shown in l chaindeficient mice (42) . Thus, his work clearly shows that the process of B-cell development and differentiation primarily depends on the expression of l chain with surrogate L chain on the B lineage cells in the pre-B-cell stage (Fig. 5 ). This work is highly regarded because it confirmed the critical role of surface l chain in vivo.
BCR signaling: Tomohiro Kurosaki
As mentioned above, it was getting clear that the BCR plays a central role in determining the fate decision of B cells even before they encounter antigen. For instance, the pre-BCR and its associated signaling subunits Iga and Igb are essential for progression through the pre-B-cell stage. The signaling ability is mandatory for developmental progression as well as immune responses in that deletion of only the cytoplasmic regions of Iga-Igb renders B cells arrested before the pre-B-cell stage.
Japanese scientists have also contributed to understanding such signaling aspects. By taking advantage of the high propensity of homologous recombination in a chicken DT40 cell line, Tomohiro Kurosaki (currently at the Osaka University and the RIKEN Research Center for Allergy and Immunology) established Lyn-, Syk-and Bruton agammalobulinemia tyrosine kinase (Btk)-deficient DT40 B cells and defined the importance of these three types of intracellular tyrosine kinases in BCR signaling. Furthermore, by carefully examining the activation kinetics of these kinases, Kurosaki's group showed that concerted action of Lyn, Syk and Btk leads to activation of a variety of signaling pathways such as lipid-metabolizing enzymes including PLCsc2 and PI3-kinase (43) (44) (45) .
These studies clarified connections between tyrosine kinases and lipid-metabolizing enzymes but did not tell us the connecting mechanisms. For this purpose, Kurosaki's group purified tyrosine-phosphorylated proteins and then identified adapter molecules, BLNK and B-cell receptorassociated protein (BCAP) (46, 47) . BLNK alternatively named B-cell adapter containing src-homology 2 (SH2) domain] was also identified as one of the critical signaling molecules by Kitamura (48) . After various genetic and biochemical experiments, Satoshi Tsukada and Kurosaki first proposed the model in which BLNK is phosphorylated by Syk and provides docking sites for Btk SH2 domains as well as PLCc2 SH2 domains, thus bringing Btk into close proximity with PLCc2 (Fig. 6) . The activated Btk then phosphorylates PLCc2, leading to its activation (49) . Similarly, BCAP and CD19, after being phosphorylated, provide binding sites for PI3-kinase (50).
The discovery of cytokines important in B-cell biology: Kiyoshi Takatsu, Toshio Hirano and Tadamitsu Kishimoto
On the basis of the evidence that B cells are responsible for making antibodies, during the 1960s, the above researchers and their colleagues focused more on cellular-level analyses of B cells, namely how these B cells proliferate and differentiate into plasma cells. Kiyoshi Takatsu (currently at the University of Toyama) was one of the pioneers in this field. After his highly focused studies of suppressor T cells in IgE formation, Takatsu published a series of papers on T-cell-replacing factor (TRF; also termed B-cell growth factor II), a factor that can induce the growth and differentiation of murine-activated B cells into Ig-producing cells (51) (52) (53) .
It should be noted that TRF has effects on various types of cells (54) and, interestingly, supports the terminal differentiation and proliferation of eosinophilic precursors (55) . Because of its functional variety and unique features, TRF is now known as IL-5, and the functions of IL-5 have been confirmed in vivo by gene transgenic or gene-deficient mice. Takatsu continued his study of IL-5 (56, 57) and also of IL-5R (58) . These studies, along with analyses of signal transduction through IL-5R, provided insights into the diverse biological activities of IL-5.
In addition to the studies of IL-5, I want to make mention of the IL-6 story obtained by Onoue, Kishimoto and Toshio Thus, though IL-6 was originally identified as a BCDF, it is now known as a multi-functional cytokine that is produced by a wide variety of cells and is involved in regulation of the immune response, hematopoiesis and also inflammation. The cloning of IL-6R (64) and an IL-6R-associated signal transducer, gp130 (65), was later carried out, and the importance of IL-6-IL-6R-gp130 signal axis is now being studied in relation to the development of autoimmune diseases such as rheumatoid arthritis and other T-cell-driven autoimmune diseases (66, 67) . Nowadays, a humanized mAb against human IL-6R (known as tocilizumab or Actemraâ) is used to treat rheumatoid arthritis, juvenile idiopathic arthritis and Castleman's disease, indicating the therapeutic possibilities of regulating an IL-6-IL-6R signal cascade.
Ly-1 B cells (B-1a B cells): Kyoko Hayakawa
In addition to conventional type B2 B cells, the existence of another type of B cells is now well known, possibly increasing the diversity of humoral responses. These Ly-1 B cells (also known as B-1a B cells) were discovered in the early 1980s by a Japanese immunologist, Kyoko Hayakawa (currently at the Fox Chase Cancer Center, Philadelphia), in the laboratory of Leonard and Leonore Herzenberg. Ly-1 B cells were reported to be a small sub-population of normal murine splenic B cells and were present at higher frequencies in NZB and NZB-related mice (68) . Hayakawa further reported that the Ly-1 B subset in these autoimmune animals and also in normal mouse strains is responsible for spontaneous IgM secretion and contains the cells that secrete typical Fig. 6 . Early BCR signaling events. After surface BCR aggregation, Lyn is activated by an unknown mechanism. Then, activated Lyn phosphorylates ITAMs within Iga-Igb, recruiting Syk into the BCR complex and leading to its activation. The activated Syk phosphorylates several tyrosine residues on BLNK, which can provide binding sites for Btk and PLCc2. Then activated Btk phosphorylates key tyrosine residues on PLCc2, leading to enhancement of the enzymatic activity of PLCc2. auto-antibodies (69) . Progenitors for Ly-1 B cells are distinct from progenitors for other B cells (70) and the majority of Ly-1 B cells is located in peritoneum (71) .
In murine studies, participation of this subset in autoimmune pathogenesis has been suggested and this was also the case in human patients. Hayakawa, when she was in Kishimoto's laboratory at Osaka University, actually showed increased frequencies of the human homologue of this subset (i.e. Leu-1 B cells) in patients with rheumatoid arthritis (72) . Thus, Hayakawa first clarified the functionally and developmentally distinct type of B cells secreting low-affinity IgM as a 'natural' antibody, then showed its functional importance as a first line of defense against bacterial pathogens and finally demonstrated that it is also involved in the pathogenesis of autoimmune diseases.
GCs and memory B cells: Hitoshi Kikutani, Toshitada Takemori, Takeshi Tokuhisa and Takeshi Watanabe Discoveries about GCs have attracted a great deal of interest from many B-cell researchers (73) . Formation of the GC results from a series of cellular interactions with activated T cells, B cells and also follicular dendritic cells. The GC is essential for B-cell immune responses; therefore, B cells proliferate rapidly while undergoing somatic mutation and class switching (74) . This process facilitates the generation of B cells possessing higher affinity BCRs, and these cells can be selected as memory B cells or antibody-forming cells with a long lifespan (Fig. 7) .
Hitoshi Kikutani (currently at Osaka University) provided the molecular basis underlying T-B interactions. Although an engagement of CD40 on B cells by CD40 ligand on T cells had been known to provide a co-stimulatory signal to B cells in vitro, by establishing CD40 knockout mice, Kikutani clearly demonstrated that CD40 is indeed essential for T-celldependent Ig class switching and GC formation in vivo (75) .
As discussed below, two Japanese scientists, Toshitada Takemori (currently at the RIKEN Research Center for Allergy and Immunology) and Takeshi Tokuhisa (currently at Chiba University) contributed to studies of the generation and maintenance of memory B cells in relation to the formation of GCs. Memory B cells are sensitized lymphocytes, and their origin is still something of an enigma. In the course of cell proliferation, point mutations in the rearranged V region genes were thought to occur frequently and for their appearance to coincide with the generation of the GC. In 1991, direct evidence for this speculation was presented, indicating that the accumulation of somatic hypermutation in Ig genes can actually be observed in GC B cells (74, 76) , and the B cells with higher affinity BCRs (surface Ig) are selected to become differentiated as either antibody-forming cells with a long lifespan or memory B cells (77) .
In 2001, Takemori and his team blazed a trail through this field, isolating antigen-binding IgG1 + B cells from primed mice and clearly showing their capacity to evoke a secondary immune response when co-transplanted with carrier-primed T h cells into immunodeficient mice that received antigenic challenge. This indicated that the specific fraction with the presumed memory B-cell phenotype was enriched with functional memory B cells and also suggested that memory B cells can be isolated by a specific molecular marker (78) .
It has been reported that GC B cells show high B-cell CLL/lymphoma 6 (Bcl-6) expression (79) , and it is well known that Bcl-6 indirectly and negatively controls the differentiation of B cells into antibody-forming cells by suppressing the expression of the B lymphocyte-induced maturation protein 1 gene. This was confirmed by Tokuhisa and his group in Bcl-6-deficient mice, in which antibody-forming cells were observed but the generation of GCs was completely inhibited (80); thus, Bcl-6 is essential for development of GCs. Furthermore, Tokuhisa also showed that memory B cells that had not accumulated somatic mutations are detected in these Bcl-6-deficient mice (81) . These characteristic memory B cells can differentiate into antibodyforming cells producing low-affinity antibodies upon antigen re-challenge.
These findings clearly indicate that the generation of memory B cells can either dependent on or, interestingly, be independent of the development of GCs. Takemori confirmed this by using mice that had been injected with antiinducible T cell co-stimulator antibody, in which IgG1 memory B cells with scarcely accumulated mutations were detected and in which secondary responses characterized by production of low-affinity antibody were also observed (82) . These findings support the notion that low-affinity memory B cells are generated in a GC-independent manner. Very recently, Kurosaki's group also examined the molecular basis for the development and survival of memory B cells, showing that PLCc2 is required for both efficient formation and maintenance of memory B cells (83) . The precise mechanism underlying the generation and maintenance of memory B cells remains unknown, and it is of importance that attempts are made to clarify the regulatory mechanisms for this process.
To examine memory B-cell studies from a different angle, I would like to briefly touch on a synthetic lymphoid tissuelike organoid system (an 'artificial lymph node') reported by Takeshi Watanabe (currently at Kyoto University) and his group. They demonstrated that a biocompatible scaffold embedded with thymus-derived stromal cells and dendritic cells can efficiently generate a lymphoid tissue-like organoid after its implantation under the renal subcapsule of recipient 
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mice. This organoid contained compartmentalized B-cell and T-cell clusters, high-endothelial venule-like vessels, GCs and follicular dendritic cell networks, thus being similar to secondary lymphoid organs (84) . It should be noted that artificial lymph nodes transplanted to normal as well as SCID mice efficiently induced secondary immune responses, and more importantly, secondary responses were maintained over time after immunization (85) . These findings clearly indicate that artificial lymph nodes can support the development of memory B cells and long-lived plasma cells and also suggest the possibility of clinical applications of artificial lymph nodes.
Conclusions
The last several decades have seen remarkable progress in our understanding of the study of B cells and antibodies. Reading through this historical sketch of B-cell studies, what impressed us is that several Japanese immunologists have made substantial contributions to this field by clarifying the mechanisms and related functional molecules underlying B-cell immunity. I hope that a number of epoch-making studies, listed here, achieved by senior researchers will greatly encourage young Japanese immunologists and hope also that they will play the leading part in this field in the near future, too.
